TY  - GEN
AU  - Arnedos,M
AU  - Bayar,M A
AU  - Cheaib,B
AU  - Scott,V
AU  - Bouakka,I
AU  - Valent,A
AU  - Adam,J
AU  - Leroux-Kozal,V
AU  - Marty,V
AU  - Rapinat,A
AU  - Mazouni,C
AU  - Sarfati,B
AU  - Bieche,I
AU  - Balleyguier,C
AU  - Gentien,D
AU  - Delaloge,S
AU  - Lacroix-Triki,M
AU  - Michiels,S
AU  - Andre,F
TI  - Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial
SN  - 1569-8041
PY  - 2019///1223
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Biopsy
KW  - Breast
KW  - pathology
KW  - Breast Neoplasms
KW  - Cell Proliferation
KW  - drug effects
KW  - Cyclin-Dependent Kinase 4
KW  - antagonists & inhibitors
KW  - Cyclin-Dependent Kinase 6
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Ki-67 Antigen
KW  - analysis
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - methods
KW  - Phosphorylation
KW  - Piperazines
KW  - Pyridines
KW  - Receptor, ErbB-2
KW  - metabolism
KW  - Receptors, Estrogen
KW  - Receptors, Progesterone
KW  - Retinoblastoma Binding Proteins
KW  - Treatment Outcome
KW  - Ubiquitin-Protein Ligases
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdy202
ER  -